(Q37059429)

18 August 2017

1 reference

title

Measuring tuberculosis burden, trends, and the impact of control programmes (English)

1 reference

18 August 2017

0 references

C Dye

1

1 reference

18 August 2017

A Bassili

2

1 reference

18 August 2017

A L Bierrenbach

3

1 reference

18 August 2017

J F Broekmans

4

1 reference

18 August 2017

V K Chadha

5

1 reference

18 August 2017

P Glaziou

6

1 reference

18 August 2017

P G Gopi

7

1 reference

18 August 2017

M Hosseini

8

1 reference

18 August 2017

S J Kim

9

1 reference

18 August 2017

D Manissero

10

1 reference

18 August 2017

I Onozaki

11

1 reference

18 August 2017

H L Rieder

12

1 reference

18 August 2017

S Scheele

13

1 reference

18 August 2017

F van Leth

14

1 reference

18 August 2017

M van der Werf

15

1 reference

18 August 2017

B G Williams

16

1 reference

18 August 2017

language of work or name

1 reference

16 January 2008

1 reference

Lancet Infectious Diseases

18 August 2017

published in

1 reference

18 August 2017

volume

8

1 reference

18 August 2017

issue

4

1 reference

18 August 2017

page(s)

233-243

1 reference

WHO's new Stop TB Strategy.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Targets for tuberculosis control: how confident can we be about the data?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Interpreting health statistics for policymaking: the story behind the headlines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Towards good practice for health statistics: lessons from the Millennium Development Goal health indicators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

An evaluation of the completeness of tuberculosis case reporting using hospital billing and laboratory data; Wisconsin, 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Varese Tuberculosis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Incidence of pulmonary tuberculosis and HIV coinfection in the province of Seville, Spain, 1998

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

An evaluation of completeness of tuberculosis notification in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

An evaluation of the actual incidence of tuberculosis in French Guiana using a capture-recapture model.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Completeness of notification of tuberculosis in The Netherlands: how reliable is record-linkage and capture-recapture analysis?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Efeito da remoção de notificações repetidas sobre a incidência da tuberculose no Brasil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Hyperendemic pulmonary tuberculosis in a Peruvian shantytown

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Recent transmission of tuberculosis in Madrid: application of capture–recapture analysis to conventional and molecular epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

The effect of tuberculosis control in China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Active community surveillance of the impact of different tuberculosis control measures, Tiruvallur, South India, 1968-2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Determining the burden of tuberculosis in Eritrea: a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Prevalence of sputum smear-positive tuberculosis in a rural area in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Follow-up tuberculosis prevalence survey of Transkei

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Do women with tuberculosis have a lower likelihood of getting diagnosed? Prevalence and case detection of sputum smear positive pulmonary TB, a population-based study from Vietnam.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

How to measure the prevalence of tuberculosis in a population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Science or marketing at WHO? A commentary on 'World Health 2000'

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Measuring health and disability

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43000 adult male deaths and 35000 controls

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Tobacco attributable deaths in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Chronic diseases now a leading cause of death in rural India--mortality data from the Andhra Pradesh Rural Health Initiative

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Verbal autopsy of 48 000 adult deaths attributable to medical causes in Chennai (formerly Madras), India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Prospective study of one million deaths in India: rationale, design, and validation results

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Validation of verbal autopsy procedures for adult deaths in China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Core verbal autopsy procedures with comparative validation results from two countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Validity of verbal autopsy procedures for determining cause of death in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Evolution of Tuberculosis Control and Prospects for Reducing Tuberculosis Incidence, Prevalence, and Deaths Globally

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Mortality of tuberculosis patients in Chennai, India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Tuberculosis and the HIV epidemic: increasing annual risk of tuberculous infection in Kenya, 1986-1996

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

The impact of the HIV epidemic on tuberculosis transmission in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Methodological issues in the estimation of the tuberculosis problem from tuberculin surveys

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Annual risk of infection with Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Is tuberculin skin testing useful to diagnose latent tuberculosis in BCG-vaccinated children?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Determination of the prevalence of infection with Mycobacterium tuberculosis among persons vaccinated against Bacillus Calmette-Guérin in South Korea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Analysis of latent tuberculosis and mycobacterium avium infection data using mixture models.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

The prognosis of latent tuberculosis: can disease be predicted?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

QuantiFERON-TB Gold: state of the art for the diagnosis of tuberculosis infection?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Interferon-gamma release assays in children – No better than tuberculin skin testing?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Serial testing of health care workers for tuberculosis using interferon-gamma assay

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

An update on the diagnosis of tuberculosis infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the Styblo rule.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Breaking a law: tuberculosis disobeys Styblo's rule

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Guidelines for conducting tuberculin skin test surveys in high prevalence countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

The dynamics of tuberculosis in response to 10 years of intensive control effort in Peru

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

Controlling tuberculosis in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2807%2970291-8

7 January 2021

10.1016/S1473-3099(07)70291-8

Identifiers

DOI

1 reference

18 August 2017

1 reference